Honeywell Slashes Johnson Matthey Acquisition Price by $640M

BenzingaBenzinga
|||1 min read
Key Takeaway

Honeywell cuts Johnson Matthey acquisition price by $640M to $1.79B, citing changed market conditions. Deal expected to close by August 2026.

Honeywell Slashes Johnson Matthey Acquisition Price by $640M

Honeywell International has renegotiated the purchase price of Johnson Matthey's Catalyst Technologies business to $1.79 billion, down from the originally agreed $2.43 billion valuation. The revised deal represents a significant reduction in the transaction's value, reflecting changed market conditions since the acquisition was first announced. The acquisition will be integrated into Honeywell's Energy and Sustainability Solutions segment upon completion.

The transaction is now expected to close by the end of August 2026, subject to customary closing conditions and regulatory approvals. The catalyst technologies business provides emissions control solutions and chemical processing technologies across industrial and environmental applications. Honeywell's acquisition of this division aligns with the company's strategic focus on sustainability-related solutions amid evolving global environmental regulations.

Market reaction to the renegotiated deal was negative, with Johnson Matthey shares declining 17% following the announcement. The price adjustment may reflect broader economic headwinds affecting industrial acquisitions or revised financial projections for the catalyst technologies division.

Source: Benzinga

Back to newsPublished Feb 23

Related Coverage

Benzinga

Mountain Commerce Bancorp Clears Regulatory Hurdles for Home BancShares Merger

Mountain Commerce Bancorp receives Federal Reserve and Arkansas regulatory approvals for merger with Home BancShares, expected to close in early Q2 2026.

HOMBMCBI
Benzinga

Smithfield Foods Surges on Robust Q4 Earnings, Nathan's Famous Deal

Smithfield Foods beat Q4 expectations with 83-cent EPS, announced $450M Nathan's Famous acquisition at $102/share, projecting $1.3-$1.5B FY26 operating profit. Stock surged 4.13%.

SFDNATH
Benzinga

Gilead Bolsters Inflammation Arsenal With $1.675B Ouro Medicines Deal

Gilead acquires Ouro Medicines for $1.675B upfront, targeting inflammation pipeline expansion. Galapagos NV partners to co-develop lead asset OM336.

GILDACLXGLPG
Benzinga

Vertiv Accelerates Capacity Push to Capitalize on AI Data Center Boom

Vertiv expands manufacturing capacity across three facilities and acquires ThermoKey to meet soaring AI data center demand for cooling and power infrastructure.

VRTAIPO
Benzinga

CVD Equipment Surges 26% on $16.9M Asset Sale to Atlas Copco

CVD Equipment ($CVV) surges 26% after agreeing to sell Stainless Design Concepts to Atlas Copco for $16.9M, netting $15M while focusing on core CVD operations.

ATLCYCVV
Benzinga

SEALSQ to Acquire Quantum Interconnect Firm Miraex in Strategic Stack Play

SEALSQ signs Letter of Intent to acquire Swiss quantum interconnect firm Miraex, completing its quantum technology stack and supporting space-based quantum infrastructure initiative.

LAESWKEY